🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to evaluate the analgesic effect of paracetamol in...
Status
Terminated
Location
Lise LACLAUTRE
Start Date
2018-08-20
Trial ID
NCT03559985
Treatments Being Tested
A study to investigate the safety and tolerability of both single and multi...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03-12
Trial ID
NCT00459550
Treatments Being Tested
This study is designed to assess the safety and tolerability of single, esc...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-29
Trial ID
NCT00605852
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Terminated
Location
Parexel Early Phase Unit at Glendale
Start Date
2022-08-11
Trial ID
NCT05486208
This is a Phase III, randomized, double-blind, double-dummy, active-compara...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2015-05-26
Trial ID
NCT02383589
Treatments Being Tested
Obesity and type 2 diabetes have clearly been linked together and identifie...
Status
Completed
Location
UC Davis
Start Date
2007-04
Trial ID
NCT00682916
Dysfunctional voiding is often associated with constipation. The associatio...
Status
Terminated
Location
Wake Forest University Health Sciences
Start Date
2009-09
Trial ID
NCT01003249
RV568 is being developed as a possible treatment of smoking related lung di...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01661244
The purpose of this study is to investigate Suprep bowel preparation, with ...
Status
Withdrawn
Location
UF Health Jacksonville
Start Date
2016-03
Trial ID
NCT02523911
Treatments Being Tested
IBI306 is a fully human monoclonal antibody that binds proprotein convertas...
Status
Completed
Location
Peking University First Hospital
Start Date
2019-03-07
Trial ID
NCT03815812